Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible EE/DRSP Regimen With/Without Levomefolate vs Standard Regimen
NCT01331655Phase 3Withdrawn
- Sponsor
- Bayer
- Start
- Apr 2013
- Primary completion
- Nov 2014
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of ethinyl estradiol, drospirenone, levomefolate calcium in contraception, sponsored by Bayer. Planned start Apr 2013; status: withdrawn.
02
Drugs
ethinyl estradioldrospirenonelevomefolate calcium
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01331655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01331655.